Recovery of the gut microbiome following fecal microbiota transplantation

mBio

Volumn 5, Issue 3, 2014, Pages

  Seekatz, Anna M ^a   Aas, Johannes ^b   Gessert, Charles E ^c   Rubin, Timothy A ^b   Saman, Daniel M ^c   Bakken, Johan S ^d   Young, Vincent B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Essentia Health   (United States)

^c ESSENTIA INSTITUTE OF RURAL HEALTH   (United States)

^d St Luke's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIDAXOMICIN; METRONIDAZOLE; RNA 16S; VANCOMYCIN;

AMINO ACID TRANSPORT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL LOAD; BACTEROIDETES; BIOLOGICAL THERAPY; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COMMUNITY STRUCTURE; CONTROLLED STUDY; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; HUMAN; INTESTINE FLORA; METAGENOMICS; MICROBIAL COMMUNITY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEOBACTERIA; RECURRENT INFECTION; THERAPY EFFECT; ADULT; AGED; BACTERIA; CLASSIFICATION; CLINICAL TRIAL; CLOSTRIDIUM INFECTIONS; FECES; FEMALE; GASTROINTESTINAL TRACT; GENETICS; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; MOLECULAR GENETICS; PEPTOCLOSTRIDIUM DIFFICILE; PHYLOGENY; PHYSIOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BACTERIA; BIOLOGICAL THERAPY; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FECES; FEMALE; GASTROINTESTINAL TRACT; HUMANS; MALE; MICROBIOTA; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY;

EID: 84903954202     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00893-14     Document Type: Article

References (38)

1. Ananthakrishnan AN. 2011. Clostridium difficile infection: epidemiology, risk factors and management. Nat. Rev. Gastroenterol. Hepatol. 8: 17-26. http://dx. doi. org/10. 1038/nrgastro. 2010. 190.
2. Dubberke ER, Olsen MA. 2012. Burden of Clostridium difficile on the healthcare system. Clin. Infect. Dis. 55(Suppl 2): S88-S92. http://dx. doi. org/10. 1093/cid/cis335.
3. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH, Society for Healthcare Epidemiology of America, Infectious Diseases Society of America. 2010. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect. Control Hosp. Epidemiol. 31: 431-455. http://dx. doi. org/10. 1086/651706.
4. Musher DM, Aslam S, Logan N, Nallacheru S, Bhaila I, Borchert F, Hamill RJ. 2005. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin. Infect. Dis. 40: 1586-1590. http://dx. doi. org/10. 1086/430311.
5. Kelly CP. 2012. Current strategies for management of initial Clostridium difficile infection. J. Hosp. Med. 7(Suppl 3): S5-S10. http://dx. doi. org/10. 1002/jhm. 1909.
6. van der Waaij D. 1989. The ecology of the human intestine and its consequences for overgrowth by pathogens such as Clostridium difficile. Annu. Rev. Microbiol. 43: 69-87. http://dx. doi. org/10. 1146/annurev. micro. 43. 1. 69.
7. Khoruts A, Dicksved J, Jansson JK, Sadowsky MJ. 2010. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J. Clin. Gastroenterol. 44: 354-360. http://dx. doi. org/10. 1097/MCG. 0b013e3181c87e02.
8. Antharam VC, Li EC, Ishmael A, Sharma A, Mai V, Rand KH, Wang GP. 2013. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea. J. Clin. Microbiol. 51: 2884-2892. http://dx. doi. org/10. 1128/JCM. 00845-13.
9. Chang JY, Antonopoulos DA, Kalra A, Tonelli A, Khalife WT, Schmidt TM, Young VB. 2008. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J. Infect. Dis. 197: 435-438. http://dx. doi. org/10. 1086/525047.
10. Theriot CM, Young VB. 2014. Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection. Gut Microbes 5: 86-95. http://dx. doi. org/10. 4161/gmic. 27131.
11. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, Visser CE, Kuijper EJ, Bartelsman JF, Tijssen JG, Speelman P, Dijkgraaf MG, Keller JJ. 2013. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368: 407-415. http://dx. doi. org/10. 1056/NEJMoa1205037.
12. Brandt LJ, Aroniadis OC. 2013. An overview of fecal microbiota transplantation: techniques, indications, and outcomes. Gastrointest. Endosc. 78: 240-249. http://dx. doi. org/10. 1016/j. gie. 2013. 03. 1329.
13. Yoon SS, Brandt LJ. 2010. Treatment of refractory/recurrent C. difficileassociated disease by donated stool transplanted via colonoscopy: a case series of 12 patients. J. Clin. Gastroenterol. 44: 562-566. http://dx. doi. org/10. 1097/MCG. 0b013e3181dac035.
14. Hamilton MJ, Weingarden AR, Unno T, Khoruts A, Sadowsky MJ. 2013. High-throughputDNAsequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria. Gut Microbes 4: 125-135. http://dx. doi. org/10. 4161/gmic. 23571.
15. Lawley TD, Clare S, Walker AW, Stares MD, Connor TR, Raisen C, Goulding D, Rad R, Schreiber F, Brandt C, Deakin LJ, Pickard DJ, Duncan SH, Flint HJ, Clark TG, Parkhill J, Dougan G. 2012. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog. 8: e1002995. http://dx. doi. org/10. 1371/journal. ppat. 1002995.
16. Reeves AE, Koenigsknecht MJ, Bergin IL, Young VB. 2012. Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family Lachnospiraceae. Infect. Immun. 80: 3786-3794. http://dx. doi. org/10. 1128/IAI. 00647-12.
17. Weingarden AR, Chen C, Bobr A, Yao D, Lu Y, Nelson VM, Sadowsky MJ, Khoruts A. 2014. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am. J. Physiol. Gastrointest. Liver Physiol. 306: G310-G319. http://dx. doi. org/10. 1152/ajpgi. 00282. 2013.
18. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, Sahl JW, Stres B, Thallinger GG, Van Horn DJ, Weber CF. 2009. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75: 7537-7541. http://dx. doi. org/10. 1128/AEM. 01541-09.
19. Wang Q, Garrity GM, Tiedje JM, Cole JR. 2007. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73: 5261-5267. http://dx. doi. org/10. 1128/AEM. 00062-07.
20. Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, Clemente JC, Burkepile DE, Vega Thurber RL, Knight R, Beiko RG, Huttenhower C. 2013. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol. 31: 814-821. http://dx. doi. org/10. 1038/nbt. 2676.
21. Abubucker S, Segata N, Goll J, Schubert AM, Izard J, Cantarel BL, Rodriguez-Mueller B, Zucker J, Thiagarajan M, Henrissat B, White O, Kelley ST, Methé B, Schloss PD, Gevers D, Mitreva M, Huttenhower C. 2012. Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput. Biol. 8: e1002358. http://dx. doi. org/10. 1371/journal. pcbi. 1002358.
22. Feehily C, Karatzas KA. 2013. Role of glutamate metabolism in bacterial responses towards acid and other stresses. J. Appl. Microbiol. 114: 11-24. http://dx. doi. org/10. 1111/j. 1365-2672. 2012. 05434. x.
23. Song Y, Garg S, Girotra M, Maddox C, von Rosenvinge EC, Dutta A, Dutta S, Fricke FW. 2013. Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infect i o n. PLoS One 8: e 8 1 3 3 0. h t t p://d x. d o i. o r g/1 0. 1 3 7 1/journal. pone. 0081330.
24. Angelberger S, Reinisch W, Makristathis A, Lichtenberger C, Dejaco C, Papay P, Novacek G, Trauner M, Loy A, Berry D. 2013. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am. J. Gastroenterol. 108: 1620-1630. http://dx. doi. org/10. 1038/ajg. 2013. 257.
25. Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, Reyes JA, Shah SA, LeLeiko N, Snapper SB, Bousvaros A, Korzenik J, Sands BE, Xavier RJ, Huttenhower C. 2012. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 13: R79. http://dx. doi. org/10. 1186/gb-2012-13-9-r79.
26. McHardy IH, Goudarzi M, Tong M, Ruegger PM, Schwager E, Weger JR, Graeber TG, Sonnenburg JL, Horvath S, Huttenhower C, McGovern DPB, Fornace AJ, Borneman J, Braun J. 2013. Integrative analysis of the microbiome and metabolome of the human intestinal mucosal surface reveals exquisite inter-relationships. Microbiome 1: 17. http://dx. doi. org/10. 1186/2049-2618-1-17.
27. Karasawa T, Ikoma S, Yamakawa K, Nakamura S. 1995. A defined growth medium for Clostridium difficile. Microbiology 141: 371-375. http://dx. doi. org/10. 1099/13500872-141-2-371.
28. Perez-Cobas AE, Artacho A, Knecht H, Ferrus ML, Friedrichs A, Ott SJ, Moya A, Latorre A, Gosalbes MJ. 2013. Differential effects of antibiotic therapy on the structure and function of human gut microbiota. PLoS One 8: e80201. http://dx. doi. org/10. 1371/journal. pone. 0080201.
29. Theriot CM, Koenigsknecht MJ, Carlson PE, Hatton GE, Nelson AM, Li B, Huffnagle GB, Li JZ, Young VB. 2014. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increases susceptibility to Clostridium difficile infection. Nat. Commun 5: 3114. http://dx. doi. org/10. 1038/ncomms4114.
30. Quera R, Espinoza R, Estay C, Rivera D. 2014. Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection. J. Crohns Colitis 8: 252-253. http://dx. doi. org/10. 1016/j. crohns. 2013. 10. 002.
31. Schwartz M, Gluck M, Koon S. 2013. Norovirus gastroenteritis after fecal microbiota transplantation for treatment of Clostridium difficile infection despite asymptomatic donors and lack of sick contacts. Am. J. Gastroenterol. 108: 1367. http://dx. doi. org/10. 1038/ajg. 2013. 164.
32. De Leon LM, Watson JB, Kelly CR. 2013. Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin. Gastroenterol. Hepatol. 11: 1036-1038. http://dx. doi. org/10. 1016/j. cgh. 2013. 04. 045.
33. Aas J, Gessert CE, Bakken JS. 2003. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin. Infect. Dis. 36: 580-585. http://dx. doi. org/10. 1086/367657.
34. Hashway SA, Bergin IL, Bassis CM, Uchihashi M, Schmidt KC, Young VB, Aronoff DM, Patton DL, Bell JD. 2014. Impact of a hormonereleasing intrauterine system on the vaginal microbiome: a prospective baboon model. J. Med. Primatol. 43: 89-99. http://dx. doi. org/10. 1111/jmp. 12090.
35. Oksanen J, Blanchet FG, Kindt R, Legendre P, Minchin PR, O'Hara RB, Simpson GL, Solymos P, Stevens MHH, Wagner H. 2013. Vegan: Community Ecology R Package, v2. 0-10. http://vegan. r-forge. rproject. org/.
36. Warnes GR, Bolker B, Bonebakker L, Gentleman R, Liaw WHA, Lumley T, Maechler M, Magnusson A, Moeller S, Schwartz M, Venables B. 2013. Gplots: various R programming tools for plotting data, v2. 12. 1. http://cran. r-project. org/web/packages/gplots/index. html.
37. Kuczynski J, Stombaugh J, Walters WA, Gonzalez A, Caporaso JG, Knight R. 2012. Using QIIME to analyze 16S rRNA gene sequences from microbial communities. Curr. Protoc. Microinform. 36: 10. 7. 1-10. 7. 20. http://dx. doi. org/10. 1002/0471250953. bi1007s36.
38. Kanehisa M, Goto S. 2000. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28: 27-30. http://dx. doi. org/10. 1093/nar/28. 7. e27.